All In MedTech

Device Trial Radar · NCT02924857

The Chocolate Touch Study

A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions

Last checked: Nov 20, 2026Latest source record: Oct 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 333 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

333

Actual

Start

Jul 26, 2017

Primary completion

Jun 2025

Study completion Dec 2026

Sponsor

Lead sponsor
TriReme Medical, LLCNot on our public-company list
Sponsor type
Industry
First posted
Oct 5, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Chocolate Touch study is a randomized, multi-center, prospective, adaptive study, designed to show sufficient safety and effectiveness of the Chocolate Touch™ for use in superficial femoral or popliteal arteries with the intention of obtaining regulatory approval to market this device in the United States

Conditions

  • Peripheral Artery Disease (PAD)
  • Ischemia
  • Intermittent Claudication

Interventions

  • Chocolate TouchDevice

    The Chocolate Touch™ Paclitaxel Coated Balloon Catheter is indicated for balloon dilatation, after appropriate vessel preparation as needed, of lesions in native superficial femoral or popliteal arteries up to 18 cm in length that are appropriate for angioplasty with balloon diameters from 3.5 mm to 6.0mm.

  • Lutonix Drug Coated BalloonDevice

    The Lutonix® 035 Drug Coated Balloon Catheter is indicated for improving luminal diameter for the treatment of obstructive de novo or non-stented restenotic lesions (≤ 18 cm in length) in native femoropopliteal arteries having reference vessel diameters of 4 mm to 6 mm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. True Drug Coated Balloon SuccessTime frame: 12 months

1 more outcomes with a free account

Locations

20 sites in 4 countries. Site status is shown where the registry gives one.

  • Cardiac and Vascular Institute

    Gainesville, Florida

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.